Bevacizumab in refractory gastrointestinal bleeding after liver transplant: An alternative for persistent Angiodysplasias. // Journal of Liver Transplantation. – URL: https://www.sciencedirect.com/science/article/pii/S2666967626000371?dgcid=rss_sd_all
Bevacizumab in refractory gastrointestinal bleeding after liver transplant: An alternative for persistent Angiodysplasias. Journal of Liver Transplantation. https://www.sciencedirect.com/science/article/pii/S2666967626000371?dgcid=rss_sd_all
“Bevacizumab in refractory gastrointestinal bleeding after liver transplant: An alternative for persistent Angiodysplasias.” Journal of Liver Transplantation.
@article{article54046,
title = {Bevacizumab in refractory gastrointestinal bleeding after liver transplant: An alternative for persistent Angiodysplasias},
journal = {Journal of Liver Transplantation},
url = {https://www.sciencedirect.com/science/article/pii/S2666967626000371?dgcid=rss_sd_all}
}